Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings
Author(s) -
Barbara Castelnuovo,
Joseph B. Sempa,
Kiragga Agnes,
Moses R. Kamya,
Yukari C. Manabe
Publication year - 2011
Publication title -
aids research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.749
H-Index - 27
eISSN - 2090-1259
pISSN - 2090-1240
DOI - 10.1155/2011/736938
Subject(s) - medicine , resource (disambiguation) , antiretroviral therapy , human immunodeficiency virus (hiv) , antiretroviral treatment , intensive care medicine , viral load , virology , computer science , computer network
Our objective was to evaluate outcomes in patients with sustained viral suppression compared to those with episodes of viremia. Methods . In a prospective cohort of patients started on ART in Uganda and followed for 48 months, patients were categorized according to viral load (VL): (1) sustained-suppression: (VL ≤1,000 copies/mL) (2) VL 1,001–10,000, or (3) VL >10,000. Results . Fifty-Three (11.2%) and 84 (17.8%) patients had a first episode of intermediate and high viremia, respectively. Patients with sustained suppression had better CD4+ T cell count increases over time compared to viremic patients ( P < .001). The majority of patients with viremia achieved viral suppression when the measurement was repeated. Only 39.6% of patients with intermediate and 19.1% with high viremia eventually needed to be switched to second line ( P = .008). Conclusions . The use of at least one repeat measurement rather than a single VL measurement could avert from 60% to 80% of unnecessary switches.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom